A Study of CM336 in Patients With Relapsed or Refractory Multiple Myeloma

NCT05299424 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: CM336_group 1
DRUG: CM336_group 2a
DRUG: CM336_group 2b
DRUG: CM336_group 3a
DRUG: CM336_group 3b
DRUG: CM336_group 4a
DRUG: CM336_group 4b
DRUG: CM336_group 5
DRUG: CM336_group 6a
DRUG: CM336_group 6b
DRUG: CM336_group 7
DRUG: CM336_group 8a
DRUG: CM336_group 8b
DRUG: CM336_group 9
DRUG: CM336_RP2D

Sponsor

Keymed Biosciences Co.Ltd